Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease
Cardiovascular disease (CVD) is responsible for the majority of deaths in the developed world. Particularly, in patients with chronic kidney disease (CKD), the imbalance of calcium and phosphate may lead to the acceleration of both vascular and valve inflammation and calcification. One in two patien...
Main Authors: | Brena F. Sena, Jose Luiz Figueiredo, Elena Aikawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fcvm.2017.00088/full |
Similar Items
-
Roles and Regulation of Extracellular Vesicles in Cardiovascular Mineral Metabolism
by: Mark C. Blaser, et al.
Published: (2018-12-01) -
Quantification of calcified particles in human valve tissue reveals asymmetry of calcific aortic valve disease development
by: Katsumi Yabusaki, et al.
Published: (2016-11-01) -
Study of serum sclerostin levels and its role in vascular calcification in patients with chronic kidney disease
by: Ahmed R Elarbagy, et al.
Published: (2019-01-01) -
Regulatory Role of Sex Hormones in Cardiovascular Calcification
by: Holly J. Woodward, et al.
Published: (2021-04-01) -
Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification
by: Bongkun Choi, et al.
Published: (2021-01-01)